Product Description
Anti-TNFRSF8 (Brentuximab-LC-N152) -DBCO-MMAF ADC | ADC-W-260 | Creative Biolabs
Short Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant, LC-N152) conjugated via a DBCO linker to MMAF
Status: In stock
Expected Delivery Time: 9-11Weeks